Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sivan Gazit

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Cancer Epidemiology|October 2, 2024
Mapping the patient journey and treatment patterns in early-stage (stage I-III) non-small cell lung cancerSarah Sharman Moser, Shira Yaari, Lior Apter, et al.
Diabetes, Obesity & Metabolism|April 29, 2024
Real-world effectiveness of sodium-glucose cotransporter-2 inhibitors on the progression of chronic kidney disease in patients without diabetes, with and without albuminuriaAfif Nakhleh, Muhammad Abdul-Ghani, Sivan Gazit, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 7, 2022
SARS-CoV-2 spike IgG titres up to 137 days following Comirnaty mRNA COVID-19 vaccination, Israel, February to May 2021Tal Patalon, Shay Ben Moshe, Asaf Peretz, et al.
Nature Medicine|June 11, 2021
Community-level evidence for SARS-CoV-2 vaccine protection of unvaccinated individualsOren Milman, Idan Yelin, Noga Aharony, et al.
The British Journal of Ophthalmology|September 3, 2025
Topical β-blockers for treatment of glaucoma and the risk of Parkinson's diseaseAmit Meshi, Nir Giladi, Alon Zahavi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2021
The Effectiveness of the Two-Dose BNT162b2 Vaccine: Analysis of Real-World DataGabriel Chodick, Lilac Tene, Ran S Rotem, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort StudySivan Gazit, Roei Shlezinger, Galit Perez, et al.
Annals of Internal Medicine|February 14, 2022
The Incidence of SARS-CoV-2 Reinfection in Persons With Naturally Acquired Immunity With and Without Subsequent Receipt of a Single Dose of BNT162b2 Vaccine : A Retrospective Cohort StudySivan Gazit, Roei Shlezinger, Galit Perez, et al.
Advances in Therapy|July 8, 2024
Risk for Mortality in High versus Low Antiparkinsonian Therapy Dose During the First Year of Parkinson's Disease: A Real-World StudyYael Barer, Olga Sánchez-Soliño, Gabriel Chodick, et al.
The Journal of Molecular Diagnostics : JMD|November 26, 2021
SARS-CoV-2 RT-qPCR Test Detection Rates Are Associated with Patient Age, Sex, and Time since DiagnosisMatan Levine-Tiefenbrun, Idan Yelin, Hedva Uriel, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Cancer Epidemiology|October 2, 2024
Mapping the patient journey and treatment patterns in early-stage (stage I-III) non-small cell lung cancerSarah Sharman Moser, Shira Yaari, Lior Apter, et al.
Diabetes, Obesity & Metabolism|April 29, 2024
Real-world effectiveness of sodium-glucose cotransporter-2 inhibitors on the progression of chronic kidney disease in patients without diabetes, with and without albuminuriaAfif Nakhleh, Muhammad Abdul-Ghani, Sivan Gazit, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 7, 2022
SARS-CoV-2 spike IgG titres up to 137 days following Comirnaty mRNA COVID-19 vaccination, Israel, February to May 2021Tal Patalon, Shay Ben Moshe, Asaf Peretz, et al.
Nature Medicine|June 11, 2021
Community-level evidence for SARS-CoV-2 vaccine protection of unvaccinated individualsOren Milman, Idan Yelin, Noga Aharony, et al.
The British Journal of Ophthalmology|September 3, 2025
Topical β-blockers for treatment of glaucoma and the risk of Parkinson's diseaseAmit Meshi, Nir Giladi, Alon Zahavi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 17, 2021
The Effectiveness of the Two-Dose BNT162b2 Vaccine: Analysis of Real-World DataGabriel Chodick, Lilac Tene, Ran S Rotem, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort StudySivan Gazit, Roei Shlezinger, Galit Perez, et al.
Annals of Internal Medicine|February 14, 2022
The Incidence of SARS-CoV-2 Reinfection in Persons With Naturally Acquired Immunity With and Without Subsequent Receipt of a Single Dose of BNT162b2 Vaccine : A Retrospective Cohort StudySivan Gazit, Roei Shlezinger, Galit Perez, et al.
Advances in Therapy|July 8, 2024
Risk for Mortality in High versus Low Antiparkinsonian Therapy Dose During the First Year of Parkinson's Disease: A Real-World StudyYael Barer, Olga Sánchez-Soliño, Gabriel Chodick, et al.
The Journal of Molecular Diagnostics : JMD|November 26, 2021
SARS-CoV-2 RT-qPCR Test Detection Rates Are Associated with Patient Age, Sex, and Time since DiagnosisMatan Levine-Tiefenbrun, Idan Yelin, Hedva Uriel, et al.
Pageof 8